Lexaria Bioscience LEXX
NASDAQ LEXX
$10.91 -0.36 (-3.15%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lexaria Bioscience (LEXX) Amortizatization of Intangibles (2015 - 2026)

Lexaria Bioscience (LEXX) posted Amortizatization of Intangibles of $1664.0 for Q2 2026, down 7.66% sequentially from $1802.0 in Q1 2026, and down 24.33% YoY from $2199.0 in Q2 2025.

Lexaria Bioscience (LEXX) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends

Lexaria Bioscience has reported Amortizatization of Intangibles for 5 years, with the latest figure at $1664.0 in Q2 2026.

  • Quarterly Amortizatization of Intangibles fell 24.33% year-over-year to $1664.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $7473.0 (down 8.28% YoY) and the FY2025 annual result came in at $9047.0, up 35.6% from the prior year.
  • Amortizatization of Intangibles retreated to $1664.0 in Q2 2026 per LEXX's latest filing, from $1802.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $2773.0 in Q1 2024 and troughed at $67.0 in Q4 2023.
  • A 4-year average of $1920.2 and a median of $2070.0 in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2024 and 2026: Amortizatization of Intangibles jumped 3558.21% in 2024, then dropped 24.33% in 2026.
  • Over 4 years, Amortizatization of Intangibles stood at $67.0 in 2023, then surged by 3558.21% to $2451.0 in 2024, then slipped by 20.97% to $1937.0 in 2025, then declined by 14.09% to $1664.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1664.0, $1802.0, and $1937.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Lexaria Bioscience 10.15 Mn 6.54 Mn - 1,664.00

Historic Data

Download Data
DateValue
May 31, 2026 1,664.00
May 31, 2026 1,664.00
Feb 28, 2026 1,802.00
Feb 28, 2026 1,802.00
Nov 30, 2025 1,937.00
Nov 30, 2025 1,937.00
Aug 31, 2025 2,070.00
Aug 31, 2025 2,070.00
May 31, 2025 2,199.00
May 31, 2025 2,199.00
Feb 28, 2025 2,327.00
Feb 28, 2025 2,327.00
Nov 30, 2024 2,451.00
Nov 30, 2024 2,451.00
Aug 31, 2024 1,171.00
Aug 31, 2024 1,171.00
May 31, 2024 2,661.00
May 31, 2024 2,661.00
Feb 29, 2024 2,773.00
Feb 29, 2024 2,773.00